Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC). Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

STEP Perspect. 1996 Fall;8(3):5-6. Unique Identifier : AIDSLINE AIDS/97702551
Schouten JT; Whittemore S

Abstract: Disseminated Mycobacterium avium complex (DMAC) is the third most common opportunistic infection in people with AIDS, infecting up to 50 percent of them. Symptoms include high fever, weight loss, fatigue, diarrhea, poor appetite, night sweats, and anemia. Diagnosis is by blood culture. Results of two recent studies are presented, as well as treatment guidelines issued by a national panel.

Keywords: AIDS-Related Opportunistic Infections/*DRUG THERAPY/*PREVENTION & CONTROL Anti-Inflammatory Agents, Steroidal/ADMINISTRATION & DOSAGE Antibiotics, Antitubercular/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS Antibiotics, Macrolide/ADMINISTRATION & DOSAGE Antifungal Agents/ADMINISTRATION & DOSAGE Azithromycin/ADMINISTRATION & DOSAGE Clarithromycin/ADMINISTRATION & DOSAGE Clinical Trials Dexamethasone/ADMINISTRATION & DOSAGE Drug Interactions Drug Resistance, Microbial Drug Therapy, Combination Ethambutol/ADMINISTRATION & DOSAGE Fluconazole/ADMINISTRATION & DOSAGE Human Mycobacterium avium-intracellulare Infection/*DRUG THERAPY/ *PREVENTION & CONTROL Rifabutin/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS Risk Factors Uveitis/CHEMICALLY INDUCED NEWSLETTER ARTICLE
970830
M9781200

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .